ENDONOVO THERAPEUTICS, INC. (ENDV) Net margin 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) net profit margin by fiscal year — reported net income divided by reported revenue.
-13649.2%FY2022 · since FY2013: -12634.5% → -13649.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -13649.2% | -9402.0 pp |
| FY2021 | -4247.2% | -4008.6 pp |
| FY2020 | -238.6% | +5343.8 pp |
| FY2019 | -5582.4% | +2147.2 pp |
| FY2018 | -7729.5% | — |
| FY2015 | -158633.9% | -154667.7 pp |
| FY2014 | -3966.2% | +8668.3 pp |
| FY2013 | -12634.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ENDV financial trends
ENDV RevenueENDV Net incomeENDV Gross profitENDV Gross marginENDV Operating incomeENDV Operating marginENDV Operating cash flowENDV Free cash flowENDV Capital expendituresENDV Return on equityENDV Stock buybacksENDV Dividends paidENDV Total assetsENDV Total liabilitiesENDV Shareholders’ equityENDV overview →